We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

136 hedge funds and large institutions have $279M invested in PDL BioPharma, Inc. in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $245K | Put options by funds: $75K

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

7% more capital invested

Capital invested by funds: $260M → $279M (+$18.4M)

2% more funds holding

Funds holding: 133 → 136 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

24% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 46

Holders
136
Holders Change
+3
Holders Change %
+2.26%
% of All Funds
2.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
35
Reduced
46
Closed
16
Calls
$245K
Puts
$75K
Net Calls
+$170K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$8.91M
2
Goldman Sachs
Goldman Sachs
New York
+$3.88M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$2.4M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.38M
5
CCM
Context Capital Management
California
+$2.21M

Top Sellers

Rank Fund Capital Flow
1
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.42M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.18M
3
Charles Schwab
Charles Schwab
California
-$1.91M
4
ECM
Engine Capital Management
New York
-$1.53M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of New Jersey Common Pension Fund D
26
State of New Jersey Common Pension Fund D
New Jersey
$2.24M – – –
Arrowstreet Capital
27
Arrowstreet Capital
Massachusetts
$2.24M +$2.38M +752,481 +4,533%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$2.05M +$85.2K +26,954 +4%
CCM
29
Context Capital Management
California
$2.04M +$2.21M +700,172 New
Prudential Financial
30
Prudential Financial
New Jersey
$1.98M +$2.15M +680,071 New
Invesco
31
Invesco
Georgia
$1.75M -$114K -36,155 -6%
WFI
32
West Family Investments
California
$1.75M -$270K -85,333 -14%
RC
33
RBF Capital
California
$1.75M – – –
N
34
Nuveen
North Carolina
$1.48M +$2.52K +798 +0.2%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.48M -$3.35K -1,059 -0.2%
Federated Hermes
36
Federated Hermes
Pennsylvania
$1.23M -$50.2K -15,888 -4%
Wells Fargo
37
Wells Fargo
California
$953K +$124K +39,287 +14%
Axa
38
Axa
France
$927K -$128K -40,500 -11%
PPA
39
Parametric Portfolio Associates
Washington
$813K -$256K -80,857 -22%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$730K +$949 +300 +0.1%
Barclays
41
Barclays
United Kingdom
$720K +$86K +27,203 +12%
CS
42
Credit Suisse
Switzerland
$714K +$581K +183,654 +298%
Swiss National Bank
43
Swiss National Bank
Switzerland
$705K +$62.6K +19,800 +9%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$656K +$11.1K +3,521 +2%
Jane Street
45
Jane Street
New York
$624K +$679K +214,559 New
Victory Capital Management
46
Victory Capital Management
Texas
$601K -$540K -170,652 -45%
CAC
47
Cowen and Company
New York
$588K +$639K +202,162 New
AWW
48
Alan W. Weber
$582K – – –
KBC Group
49
KBC Group
Belgium
$562K -$97K -30,682 -14%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$506K – – –
1
2
3 4 5

PDLI Hedge Fund Activity: Q2 2020 in Review

136 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2020, worth a combined $279M — up 7.1% from $260M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new PDLI positions and 16 closed out — a net gain of 4 holders — while 35 added to existing stakes and 46 trimmed.

The largest buyer was State Street, adding an estimated $8.91M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), cutting an estimated $2.42M.

  • 136 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2020, up from 133 in Q1 2020.
  • Funds reported $279M of PDL BioPharma, Inc. stock for Q2 2020, up 7.1% quarter-over-quarter.
  • 20 funds opened new PDL BioPharma, Inc. positions in Q2 2020 and 16 closed out, a net change of +4 holders.
  • The largest PDL BioPharma, Inc. buyer in Q2 2020 was State Street, an estimated $8.91M added.
  • The largest PDL BioPharma, Inc. seller in Q2 2020 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $2.42M sold.

Based on aggregated 13F filings for Q2 2020.